Related Experiment Videos
[Management of patients with phenylketonuria in Mexico]
Insights
Early dietary management for phenylketonuria (PKU) is crucial for normal development. This study highlights that timely intervention, ideally through neonatal screening, significantly improves outcomes for children with PKU.
Area of Science:
- Metabolic disorders
- Genetics
- Pediatrics
Context:
- Phenylketonuria (PKU) is an inborn error of metabolism requiring lifelong dietary management.
- This study focuses on 9 children diagnosed with PKU at a specialized clinic.
- Dietary interventions were initiated at various ages, from before 8 weeks to after 10 months.
Purpose:
- To evaluate the outcomes of multidisciplinary dietary management in children with phenylketonuria.
- To assess the impact of age at diagnosis and dietary intervention on growth and neurodevelopment.
- To emphasize the importance of early diagnosis for optimal patient outcomes.
Summary:
- Multidisciplinary management, including geneticists, pediatricians, and nutritionists, was implemented for 9 children with PKU.
- Satisfactory phenylalanine control was achieved in most cases, with normal physical growth and development.
- Early diagnosis (by 1 month) led to normal mental development; later diagnoses (after 10 months) showed limited improvement.
Impact:
- Supports the critical role of early diagnosis and intervention in preventing cognitive deficits associated with PKU.
- Underscores the necessity of neonatal screening programs for timely PKU detection and management.
- Demonstrates that while dietary management can mitigate some effects, early intervention is key to achieving normal neurodevelopmental outcomes.
Abstract:
This paper shows the results of the dietary management of 9 children with phenylketonuria diagnosed at the Clinic for Inborn Errores of Metabolism of the Hospital del Niño-Instituto de Investigaciones Biomédicas UNAM. The age at which the diet was instituted was variable: in one case before the age of 8 weeks; in another one at 5 months and in the remainder after 10 months. The management is multidisciplinary and involves a geneticist, a pediatrician, a neurologist a psychologist, a nutritionist, and a social worker. In spite of the difficult control of the diet in some patients, in most cases satisfactory phenylalanine levels were maintained most of the time. The body growth and development have been normal. With regard to the mental development, the results support the importance of an early diagnosis since the case treated from the age of one month has shown normal development; the patient diagnosed at 5 months has had a low normal IQ and the rest, all diagnosed after 10 months of age, show some improvement, but do not reach normal levels. The need of neonatal screening for early diagnosis is emphazised.